These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9463022)

  • 1. [Insulin sensitivity and hepatic glucose production: nycthemeral variations].
    Gautier JF; Cathelineau G
    Diabetes Metab; 1997 Nov; 23 Suppl 4():35-8. PubMed ID: 9463022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.
    Perriello G; De Feo P; Torlone E; Fanelli C; Santeusanio F; Brunetti P; Bolli GB
    Diabetologia; 1990 Jan; 33(1):52-9. PubMed ID: 2406181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rise at dawn. Why does blood glucose spike in the a.m.?
    Gebel E
    Diabetes Forecast; 2012 Mar; 65(3):28, 30. PubMed ID: 22439376
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production.
    Boden G; Chen X; Urbain JL
    Diabetes; 1996 Aug; 45(8):1044-50. PubMed ID: 8690150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of a dawn phenomenon in normal human volunteers.
    Bolli GB; De Feo P; De Cosmo S; Perriello G; Ventura MM; Calcinaro F; Lolli C; Campbell P; Brunetti P; Gerich JE
    Diabetes; 1984 Dec; 33(12):1150-3. PubMed ID: 6389230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in insulin clearance and hepatic blood flow during the night do not contribute to the 'dawn phenomenon' in type 1 diabetes.
    Widmer A; Keller U; Pasquel M; Berger W
    Horm Res; 1988; 29(5-6):197-201. PubMed ID: 3065206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morning insulin requirements. Critique of dawn and meal phenomena.
    Blackard WG; Barlascini CO; Clore JN; Nestler JE
    Diabetes; 1989 Mar; 38(3):273-7. PubMed ID: 2645185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of activated glucose counterregulation on insulin requirements in insulin-dependent diabetes mellitus.
    Bolli GB; Perriello G
    Horm Metab Res Suppl; 1990; 24():87-96. PubMed ID: 2272633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian variation of insulin requirement in insulin dependent diabetes mellitus the relationship between circadian change in insulin demand and diurnal patterns of growth hormone, cortisol and glucagon during euglycemia.
    Trümper BG; Reschke K; Molling J
    Horm Metab Res; 1995 Mar; 27(3):141-7. PubMed ID: 7607604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circadian variations in insulin concentrations and blood glucose in non-diabetics as well as insulin requirements in insulin-dependent diabetics].
    Bruns W; Jutzi E; Fischer U; Bombor H; Woltanski KP; Jahr D; Wodrig W; Albrecht G
    Z Gesamte Inn Med; 1981 Mar; 36(5):258-60. PubMed ID: 7018102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods?
    Groop LC; Widén E; Ferrannini E
    Diabetologia; 1993 Dec; 36(12):1326-31. PubMed ID: 8307264
    [No Abstract]   [Full Text] [Related]  

  • 12. Marked impairment of the effect of hyperglycaemia on glucose uptake and glucose production in insulin-dependent diabetes.
    Arnfred J; Schmitz O; Hother-Nielsen O; Orskov C; Beck-Nielsen H; Hermansen K; Christiansen JS; Alberti KG; Orskov H
    Diabet Med; 1988 Nov; 5(8):755-60. PubMed ID: 2905942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of insulin resistance in the pathophysiology of non-insulin dependent diabetes mellitus.
    Reaven GM
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():5S-12S. PubMed ID: 8299489
    [No Abstract]   [Full Text] [Related]  

  • 15. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes.
    Porcellati F; Lucidi P; Cioli P; Candeloro P; Marinelli Andreoli A; Marzotti S; Ambrogi M; Bolli GB; Fanelli CG
    Diabetes Care; 2015 Mar; 38(3):503-12. PubMed ID: 25524950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations.
    Nyholm B; Walker M; Gravholt CH; Shearing PA; Sturis J; Alberti KG; Holst JJ; Schmitz O
    Diabetologia; 1999 Nov; 42(11):1314-23. PubMed ID: 10550415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes.
    Shapiro ET; Polonsky KS; Copinschi G; Bosson D; Tillil H; Blackman J; Lewis G; Van Cauter E
    J Clin Endocrinol Metab; 1991 Feb; 72(2):444-54. PubMed ID: 1991813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic state switches between morning and evening in association with circadian clock in people without diabetes.
    Fujimoto R; Ohta Y; Masuda K; Taguchi A; Akiyama M; Yamamoto K; Nakabayashi H; Nagao Y; Matsumura T; Hiroshige S; Kajimura Y; Akashi M; Tanizawa Y
    J Diabetes Investig; 2022 Sep; 13(9):1496-1505. PubMed ID: 35429128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
    Christensen MB
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.